Related Experiment Videos
Abnormalities of developing white matter in lysosomal storage diseases
1Department of Pathology (Neuropathology), Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Journal of Neuropathology and Experimental Neurology
|September 28, 1999
Summary
Lysosomal storage diseases can impair central nervous system myelination in infants. This review examines white matter pathology, suggesting oligodendrocyte dysfunction contributes to delayed myelination.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Lysosomal storage diseases (LSDs) are inborn errors of metabolism affecting cellular function.
- Neuroradiologic studies suggest delayed central nervous system (CNS) myelination in infantile LSDs.
- This contrasts with the primary neuronal focus of many LSDs.
Purpose of the Study:
- To review neuropathologic findings in the CNS white matter of patients and animal models with LSDs.
- To correlate neuropathology with normal myelinogenesis.
- To propose mechanisms for white matter deficiency in LSDs.
Main Methods:
- Review of published neuropathologic evaluations of infantile and juvenile LSD patients.
- Examination of corresponding animal models of LSDs.
- Analysis of studies on normal myelinogenesis biochemistry and anatomy.
Main Results:
- Neuropathologic evidence indicates central white matter involvement in infantile and juvenile LSDs.
- Observed white matter pathology is consistent with impaired myelinogenesis.
- Animal models corroborate findings in human patients.
Conclusions:
- Delayed myelination in LSDs may stem from direct metabolic effects on oligodendrocytes.
- Oligodendrocyte dysfunction impacts myelin formation and maintenance.
- Secondary axonal and neuronal damage also contribute to white matter deficits in LSDs.